Email updates

Keep up to date with the latest news and content from Genome Biology and BioMed Central.

Research news

Silencing the INK4A/ARF locus

Jonathan B Weitzman

Author Affiliations

Genome Biology 2001, 2:spotlight-20010419-02  doi:10.1186/gb-spotlight-20010419-02

The electronic version of this article is the complete one and can be found online at:


Published:19 April 2001

© 2001 BioMed Central Ltd

Research news

The importance of the INK4A/CDKN2A locus, encoding the p16/INK4a and p19/ARF proteins, in tumor suppression is underscored by the high frequency of mutation or silencing of the locus in human tumors. In the April 24 Proceedings of the National Academy of Sciences, Magdinier and Wolffe describe the role of the methyl-CpG binding protein MBD2 in INK4a/ARF gene repression in cancer cells (Proc Natl Acad Sci USA 2001, 98:4990-4995). They used chromatin immunoprecipitation (ChIP) experiments to study MBD2 binding to methylated CpG islands in the promoters of the p16/INK4a and p19/ARF genes in human colon carcinoma cell lines. Magdinier and Wolffe provide a mechanism for MBD2 repression in which MBD2 binding to hypermethylated INK4a/ARF promoters excludes the acetylated histones H3 and H4, leading to gene silencing. This effect could be overcome by combined treatment with compounds that inhibit deacetylation and methylation.

References

  1. The INK4A/ARF locus and its two gene products.

    PubMed Abstract | Publisher Full Text OpenURL

  2. [http://www.pnas.org] webcite

    Proceedings of the National Academy of Sciences

  3. Identification and characterization of a family of mammalian methyl-CpG binding proteins.

    PubMed Abstract | Publisher Full Text | PubMed Central Full Text OpenURL